ABSTRACT
INTRODUCTION
Prematurity (gestational age [GA] < 37 + 0 weeks) is the main direct cause of death in newborn infants (NBIs), especially in very low birth weight (VLBW) babies (≤ 1500 g). 1 Prematurity is also a major indirect c a u s e o f d e a t h , a n d p o v e r t y i s strongly associated with a greater risk; therefore, almost 99% of neonatal deaths occurring worldwide take place in low-and middle-income countries. 2 I n a d d i t i o n , m o r e t h a n h a l f of infants who survive to hospital discharge have severe complications, which are mostly chronic and have an impact on the subject's quality of life and that of his/her family, and which require a significant amount of medical resources.
Information is needed on which r i s k f a c t o r s ( R F s ) l e a d t o s u c h outcomes in order to prioritize i n t e r v e n t i o n s a n d p l a n t h e i r development, assess the effectiveness of interventions aimed specifically at RFs, and assess national and international trends over time. 3, 4 Although results are available r e g a r d i n g V L B W i n f a n t s f r o m developed countries, few studies have assessed the morbidity and mortality of Latin American VLBW infants. 5, 6 A problem-solving strategy is for neonatal care sites to become members of specialized, collaborative, thematic networks; some of the benefits they provide include criteria standardization, resource enhancement, site comparison, and identification of the most beneficial medical practices (benchmarking). 7 This study shows the consolidation of the South American Neonatal Network (NEOCOSUR), which has monitored, for the past 15 years, the neonatal intensive care units of six South American countries (Argentina, Brazil, Chile, Paraguay, Peru, and Uruguay).
For this reason, the goals of this study included investigating RFs independently associated with mortality in VLBW infants born in T h e h y p o t h e s i s i n d i c a t e d t h a t t h e administration of antenatal corticosteroids may reduce neonatal mortality and selected morbidities in NBIs ≤ 1500 grams.
POPULATION AND METHODS
A retrospective analysis was done using a multicenter cohort of live NBIs with a birth weight (BW) between 500 g and 1500 g corresponding to the NEOCOSUR Network. Inclusion criteria were a GA equal to or greater than 24 +0 weeks, and a BW between 500 g and 1500 g. Exclusion criteria were death in the delivery room, NBI referred to another facility, and no recording of mortality to discharge.
Data were collected in a prospective, systematic manner from 26 units between January 1 st , 2000 and December 31 st , 2011, and each event was strictly defined. Data regarding the mothers and the VLBW infants from each site were entered using the online electronic database established by the Database Unit. 8 Outcome measures were neonatal mortality and morbidity at the time of hospital discharge. Independent outcome measures were maternal age at the time of delivery, level of education, antenatal care visits, twin pregnancy, diabetes, arterial hypertension, antenatal corticosteroids (complete, incomplete, or missing treatment), mode of delivery (vaginal, C-section with or without labor), gender (male/female), GA (completed weeks at the time of childbirth) by date of the last menstrual period (LMP) or early ultrasound scan (first trimester), BW (grams), BW Z-score, 9 Apgar score at 5 minutes of 0-3, resuscitation in the delivery room, and type of facility (public/private). Morbidities included respiratory distress syndrome (RDS: hyaline membrane disease), assisted mechanical ventilation and duration in days, continuous positive airway pressure (CPAP) in days, surfactant (and number of doses), bronchopulmonary dysplasia (BPD: oxygen for more than 28 days), hemodynamically significant patent ductus arteriosus (PDA), early sepsis (< 72 h) with positive blood culture, necrotizing enterocolitis (NEC: grade 2 or higher, as per Bell), intracranial hemorrhage (ICH: grade 3 or 4, as per Papile), periventricular leukomalacia (PVL), major complications combined (MCC, two or more of the following: grade 3-4 BPD-ICH, grade 2-3 NEC), and length of stay (days). The BW Z-score was estimated using an Argentine population reference. 9 Small for gestational age (SGA) and large for gestational age (LGA) were defined as per Gruenwald 11 based on weight for GA and gender above or below two points of the median Z-score, respectively. A Z-score of +2 corresponds to the 97 th percentile, whereas a Z-score of -2, to the 3 rd percentile. Z-scores corresponded to the overall population and NBIs born between 24 +0 and 32
+6
weeks. SGA and LGA were described only for NBIs born between 24 +0 and 32 +6 weeks in order to prevent over-representation of both conditions because the cut-off limit for entering the database is based on a birth weight < 1500 g.
Comparisons included the predictor score of mortality in VLBW infants developed by the NEOCOSUR Network. 12 Briefly, the NEOCOSUR score estimates the probability of death of VLBW infants considering their BW, GA, Apgar score at 5 minutes, life-threatening congenital malformations, antenatal corticosteroids, and gender. The mortality tendency analysis was done using a linear regression model.
The length of stay was defined as days from birth to discharge. For analysis purposes, deaths were censored, similarly to what has been done in survival studies.
Central tendency measures (mean, median, and proportions) and dispersion measures (standard deviation, 95% confidence interval [CI] , and interquartile range [IQR]) were estimated. The Mann-Whitney U test and Student's t test were used to compare continuous outcome measures. The χ² test with Yates' correction was used to compare categorical outcome measures.
A multiple logistic regression analysis was used to explore the independent effect of different conditions on neonatal mortality. Models were adjusted for public or private facilities, maternal age, multiple pregnancy, maternal hypertension, antenatal corticosteroids, mode of delivery, Apgar score at 5 minutes < 3, gender, GA, BW Z-score, and confirmed early sepsis. The group of survivors to discharge was established as the reference group. Results are described as adjusted odds ratio (aOR) with the corresponding 95% CI, and models were calibrated using the HosmerLemeshow test, and their discriminatory power was established using ROC curves.
Matching by antenatal corticosteroid use
The effect of administering antenatal corticosteroids was estimated in relation to neonatal mortality and morbidity of VLBW infants using the matching method, which consists in having groups that are identical in everything except for treatment. Matching methods allow establishing two samples that are as likely as possible in terms of observed covariables, similar to a randomized experiment. 13 A p -value below 0.05 was considered statistically significant. The following software programs were used: Statistica 9.0 (Statsoft, Tulsa, OK, USA), Stata 12 (College Station, Texas, USA), and EPIDAT 2.0 (PAHO/WHO and Government of Galicia).
The study was authorized by the Ethics Committee of Hospital Materno Infantil Ramón Sardá, and anonymity of both sites and patients was maintained given that only their codes were used.
RESULTS
Out of 11 991 VLBW infants entered into the database between 2000 and 2011 (12-year period), 11 455 met the eligibility criteria ( Figure 1 ).
The overall neonatal mortality rate (NMR) for the study period was 22.3% (95% CI: 21.6-23.1), and a growing trend was observed (p= 0.441, Figure 2 ). However, risk-adjusted mortality (NEOCOSUR score) decreased 60% over the study period, even though inter-site variability was high.
Overall survival to hospital discharge was 77.7%, whereas specific survival was directly related to GA: from 54% for extremely preterm infants, to 85.8% for very preterm infants, and to 90.6% for moderately preterm infants (p < 0.001).
The degree of variability of morbidity outcomes was the same as for mortality by site (data not shown).
The mothers of deceased infants were more frequently adolescents and had undergone a C-section with labor, compared to the mothers of survivors (p < 0.001) ( Table 1) .
Male gender, a lower GA, BW and BW Z-score, and SGA predominated among deceased VLBW infants in comparison with survivors. In contrast, they had almost three times more chances of being extremely preterm, showed a greater respiratory depression at birth and, therefore, twice the need for resuscitation in the delivery room (p < 0.001) ( Table 2) . Table 3 shows that, compared to survivors, deceased VLBW infants had a mortality predictor score that was three times higher, a greater rate of RDS, mechanical ventilation requirement, surfactant requirement, BPD, intraventricular hemorrhage (IVH), NEC, PDA, and early sepsis, and twice the combined score (p < 0.001).
RFs that were independently associated with a greater mortality included GA of less than 32 weeks, an Apgar score at 5 min < 3, and early sepsis. RFs that were independently associated with a lower mortality included antenatal corticosteroid use, a better BW Z-score, hypertension in pregnancy, and C-section ( Table 4) . Model adjustment was successful (Hosmer-Lemeshow, p= 0.147), and the area under the ROC curve was 0.825.
No differences were observed in NMR by volume of hospitalized NBIs. The NMR in the public sector increased to 23.2%, whereas it reached 19.8% in the private sector (OR: 1.22, 95% CI: 1.10-1.36, p < 0.001).
The frequency of major complications Figure 2 . Trend in neonatal mortality rate (NEOCOSUR, 2000 (NEOCOSUR, -2011 NMR: neonatal mortality rate. (56-59) in private ones (p= 0.121). The median length of stay was 47 days (IQR: 41 days), and significant differences were observed among sites, similar to those observed in terms of mortality and morbidity. 
Matching:
The final sample following matching included 4192 NBIs (2096 in each arm). VLBW infants whose mothers had received antenatal corticosteroids evidenced a 38% reduction in the risk of death compared to those whose mothers had not (p < 0.001). Similar effects were observed for asphyxia (OR: 0.49) and RDS (OR: 0.62). No association was identified between the other morbidities and antenatal corticosteroid use ( Table 5) .
DISCUSSION
This is the second multicenter study conducted in Latin America to explore RFs associated with neonatal mortality of VLBW infants and the impact of antenatal corticosteroids on the prevention of adverse perinatal outcomes. It is more updated, and its sample size is larger. 14 It has been demonstrated that antenatal corticosteroid use, a better BW Z-score, arterial hypertension, and C-section were factors independently associated with a lower mortality in VLBW infants, together with the impact of antenatal corticosteroids on neonatal mortality and morbidity.
Overall NMR tended to increase over the study period, with a wide variability among sites, similar to what has been published. 15 However, risk-adjusted mortality reduced remarkably, which highlights the need to adjust results when analyzing tendencies.
GA plays a major role in VLBW infants' prognosis, and survival was observed to increase progressively in association with an older GA.
T h e f o l l o w i n g f o u r g r o u p s o f f a c t o r s independently associated with an unfavorable outcome were identified: factors associated with obstetric care (no exposure to antenatal corticosteroids, vaginal delivery), factors related to biological outcome measures (male gender, prematurity < 32 weeks, intrauterine growth restriction), factors related to childbirth care (Apgar score at 5 minutes < 3), and factors associated with intensive care (early sepsis).
The characteristics of mothers whose VLBW infants had died show the strong influence of the social component and access to care on perinatal outcomes, which is consistent with a recent systematic review. 16 It is known that there is an association between hypertension during pregnancy and a small size at birth, which may speed fetal pulmonary development and, therefore, reduce neonatal mortality. 17 Although this is a highly controversial topic, some retrospective studies indicate that the rate of prematurity-related complications may be reduced if the child is born via C-section. 18, 19 These results underline the need for an early screening of antenatal RFs and an adequate labor and NBI resuscitation in relation to mortality and GA, BW, intrauterine growth restriction, and neonatal asphyxia. The wide inter-site variability has also been reported in other studies, 20, 21 and it may be accounted for by both each unit population characteristics and inherent risks, and the diagnostic and therapeutic interventions implemented in each site, especially professional conduct when providing care to preterm infants born at the threshold of viability. Another critical aspect to take into account is that there is a severe nurse shortage in Latin America, documented in a study conducted by the NEOCOSUR Network. 22 The RFs observed here to be independently associated with mortality are consistent with those previously described in several prediction models. 23, 24 The information collected by epidemiological networks allows studying the best strategies to reduce neonatal mortality and morbidity, based on processes to improve perinatal care quality. 25 Thus, VLBW infant mortality has been reported to range between 12.4% and 28% as per the neonatal networks of developed countries (the Euro Neo Net/Euro-Peristat Network, 26 the Vermont-Oxford Network, 27 the Canadian Neonatal Network, 28 the National Institute of Child Health and Human Development [NICHD] , 29 the Spanish Neonatology Society). 23 In contrast, the results obtained by the Brazilian Neonatal Research Network 30 and the Neonatology Network of Public Hospitals from the City of Buenos Aires 31 describe more unfavorable results, especially associated with a low use of antenatal corticosteroids. However, when analyzing such differences, it is necessary to consider the denominator used to estimate the mortality rate and the fact that inclusion criteria vary from one study to another, 32 in addition to differences in population, perinatal practices, and resources.
T h e m a t c h i n g m e t h o d h a s c l e a r l y demonstrated, in this wide and varied population, a maternal corticosteroid coverage of 76.5% (95% CI: 75-77), and its impact on neonatal mortality (p < 0.001). By restricting the analysis to NBIs < 35 + 0 weeks, which is at present the indication for corticosteroids, the protective effect increased slightly (aOR: 0.47; 95% CI: 0.42-0.53). During the study period, the percentage of antenatal corticosteroid use remained stable. This is similar to the findings of a Chilean study, 33 but contrasts those of a Brazilian study, 34 in which only 54% received at least one dose, whereas in the USA, 79% of pregnant women have received this drug for the past 15 years, 35 a value very close to our study.
Differences in the length of stay of VLBW infants are not just the result of nosocomial complications, and it may be speculated that such differences may be attributed to varying discharge practices.
One of the limitations of this study is that it is a retrospective analysis, and its biases and confounding factors were not controlled (the final model accounted for 20% of variability in neonatal mortality), so our results may have been affected, to a certain extent, by residual confusion. The analyzed population accounts for 8% to 40% of VLBW infants at a national level, so results cannot be generalized to the entire population.
However, this multicenter study provides data on death and survival of preterm VLBW infants with the main morbidities observed in public and private hospital units that are considered national reference perinatal care centers.
The main strengths of this study are its sample size and multicenter nature, which allowed for a geographic distribution, prospective and systematic data collection, and an adequate calibration and discrimination of the final model.
CONCLUSIONS
The independent risk of different perinatal conditions associated with neonatal mortality in VLBW infants was estimated, and the hypothesis regarding the impact of antenatal corticosteroid use in the NEOCOSUR Network was demonstrated. n
